Stock on the Move for Thursday: ERUC! April 8, 2008

Stock Market Alerts' performance stock list includes: ER Urgent Care Centers (PINKSHEETS: ERUC), LifeCell Corp. (NASDAQ: LIFC), Cardinal Health, Inc. (NYSE: CAH), Merck & Co. (NYSE: MRK).

Having announced that it has completed its current projections for 2008, ER Urgent Care Centers (PINKSHEETS: ERUC) should continue to have the attention investors. Yesterday after the markets closed, the company, a one-stop-shop where patients can receive premier health care, after-hours, at a fraction of the cost of emergency room visits, issued a press release announcing that the Urgent care industry was recently featured in a syndicated health tips medical news article.

In the Miami Herald the article was featured in Tropical Life on April 1, 2008. All of our centers throughout the State of Florida received calls asking about the information in the article. The article itself was written in the Albany Times Union under Health Tips. The ERUC business model has been catching on nationwide and the popularity of urgent care has begun to exemplify itself in the Health Care industry. "We are very pleased with the reaction to this article. The volume of calls we received was similar to the number of calls we receive after a major ad campaign," said Mark Solomon, ERUC President.

The press release also states that we at ERUC are feeling the effects of the increased popularity of urgent care. As insurance companies and primary care physicians continue to divert patients from the emergency rooms to urgent care centers, our patient visits continue to rise. We are also feeling the effects of a decline in the number of hospital emergency rooms.

Last week the company also reported that it has completed its current projections for 2008. The press release states that after calculations were completed for the year ending 2007, accountants have projected revenues for 2008 to exceed $5,100,000.00! This forecast relates directly to programs created in the first quarter of 2008 that would increase revenues without increasing costs. With advancements in billing technology as well as the implementation of these new revenue generating programs, 2008 looks to be a year of record breaking revenues. Recent changes to the SB-2 have also been released to include the removal of the financing portion of the registration. Paragon has been removed from the registration and no financing will be included at this time.

Watch this company very closely! ERUC Management Company Inc. operates ER Urgent Care Centers in the South Florida area. The "true, bona-fide," "Urgent Care Center" is a one-stop-shop where patients can receive premier health care, after-hours, at a fraction of the cost of emergency room visits. With the "Urgent Care Center" model emergency rooms will no longer lose money on ER patients with minor injuries and illnesses and the HMOs will no longer have to pay exorbitant claims for non-admitted patients. ER Urgent Care Centers create a win-win situation for everyone, filling the financial and service gap between primary care physicians (PCPs) and hospital emergency rooms.

Before the news was released, ERUC closed yesterday at under a Penny a share.

For Stock Market Alerts' in-depth profile of ER Urgent Care Centers, visit http://www.wallstreetenews.com/HotStocks/ERUC040708/default.aspx .

Other Stocks of interest yesterday were:

LifeCell Corporation (NASDAQ: LIFC) up 16.9% on 20.2 million shares traded.

LifeCell is the leading provider of innovative biological products for soft tissue repair. Surgeons use our products to restore structure, function and physiology in a variety of reconstructive, orthopedic and urogynecologic surgical procedures.

Cardinal Health, Inc. (NYSE: CAH) down 0.6% on 1.6 million shares traded.

Cardinal Health, Inc. is an $87 billion, global company serving the health-care industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients.

Merck & Co. (NYSE: MRK) up 1.9% on 22.8 million shares traded.

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufacturers and markets vaccines and medicines to address unmet medical needs.

The advertisement is provided by Wall Street Enews, a division of Stock Market Alerts LLC, an electronic broadcaster and publisher of this release, and hereafter referred to as "the company." The company received compensation for services performed for ER Urgent Care Centers (PINKSHEETS: ERUC). In 2008, the compensation is fifty five million shares (twenty million shares for current services and thirty five million shares for previous services) from third party, BAF Consulting LLC., who is non-affiliated and may hold a significant position in the stock. The company currently holds six million of those shares, as of this release; however intends to immediately continue selling its shares as this release is being circulated. The company also maintains a contractual, working relationship with Wall Street Capital Funding, who was also previously compensated stock for services rendered in 2007, and no longer holds any of the original shares compensated for those services. The company may receive additional shares for extension of its services, and any additional shares will be disclosed at such time that the company is aware of a clients desire to extend the original services. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent. The company may have received shares of a company profiled in this release prior to the dissemination of the information in this release. The company may immediately sell some or any shares in a profiled company held by the company and may have previously sold shares in a profiled company held by the company. The company's services for a company may cause the company's stock price to increase, in which event the company would make a profit when it sells its stock in a company. In addition, the company's selling of a company's stock may have a negative effect on the market price of the stock.